Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

PhaseBio Pharmaceuticals Inc. (PHAS)

4.33   -0.38 (-8.07%) 02-25 16:00
Open: 4.71 Pre. Close: 4.71
High: 4.77 Low: 4.28
Volume: 218,195 Market Cap: 125M
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary indications. Its lead product candidate is PB2452, which is a reversal agent for the antiplatelet drug ticagrelor that has completed a Phase I clinical trial, as well as developing for the treatment of patients on ticagrelor who are experiencing a major bleeding event or those who require urgent surgery. The company is also developing PB1046, a fusion protein that is in Phase IIb clinical trial for the treatment of pulmonary arterial hypertension. PhaseBio Pharmaceuticals, Inc. was founded in 2002 and is based in Malvern, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.776 - 4.806 4.806 - 4.827
Low: 4.215 - 4.249 4.249 - 4.273
Close: 4.285 - 4.335 4.335 - 4.371

Technical analysis

as of: 2020-02-25 4:32:27 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 6.20     One year: 6.94
Support: Support1: 4.28    Support2: 3.56
Resistance: Resistance1: 5.31    Resistance2: 5.94
Pivot: 5.08
Moving Average: MA(5): 4.74     MA(20): 5.10
MA(100): 4.57     MA(250): 7.42
MACD: MACD(12,26): -0.19     Signal(9): -0.10
Stochastic oscillator: %K(14,3): 13.10     %D(3): 17.72
RSI: RSI(14): 36.49
52-week: High: 16.65  Low: 2.56  Change(%): 37.5
Average Vol(K): 3-Month: 55497  10-Days: 22652

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PHAS has closed below the lower band by 2.0%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 6.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 28.77
Shares Float (M) 14.88
% Held by Insiders 19.87
% Held by Institutions 74.94
Shares Short (K) 2290
Shares Short P. Month (K)

Stock Financials

EPS -1.309
Book Value (p.s.) 2.460
PEG Ratio
Profit Margin
Operating Margin -1948.00
Return on Assets (ttm) -39.7
Return on Equity (ttm) -76.0
Qtrly Rev. Growth -41.4
Gross Profit (p.s.) -0.514
Sales Per Share
EBITDA (p.s.) -1.250
Qtrly Earnings Growth
Operating Cash Flow (M) -33.94
Levered Free Cash Flow (M) -24.63

Stock Valuations

P/E -3.31
P/E Growth Ratio -0.08
P/BV 1.76
P/S 61.85
P/CF -3.67

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.